The US Agency for International Development, USAID, has today announced US$20 million in financial support of CEPI to advance the development of vaccines against emerging infectious diseases.
The US Agency for International Development, USAID, has today announced US$20 million in financial support of CEPI to advance the development of vaccines against emerging infectious diseases.
Set up in response to the 2014-2016 Ebola outbreak in West Africa, CEPI launched in 2017 to stimulate and accelerate the development of vaccines against emerging infectious diseases and enable access to these vaccines for populations when and where they are needed to end an outbreak or curtail an epidemic, regardless of ability to pay.

The funding—which will be provided by USAID over a five-year period from 2020 and subject to Congressional approval on an annual basis—will be used to support CEPI’s vital vaccine development programmed against its current priority diseases